NICE obesity guidance (CG189) recommends a structured approach to weight management that begins with lifestyle interventionsincluding dietary modification, increased physical activity, and behavioural support
Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel
ophthalmologic monitoring is advised in high-risk patients Gastroparesis/severe GI disease : GLP-1 agonists are generally not recommended for patients with severe gastrointestinal disease, including gastroparesis Pregnancy : GLP-1 agonists are not recommended during pregnancy
This is why stopping suddenly can sometimes feel different, not unsafe, but noticeable
The rise of skinny culture could be the culprit
Sometimes adjusting injection timing, meal composition, or dose frequency can reduce discomfort